113 related articles for article (PubMed ID: 21651557)
1. Cytochrome P450 mediates dopamine formation in the brain in vivo.
Bromek E; Haduch A; Gołembiowska K; Daniel WA
J Neurochem; 2011 Sep; 118(5):806-15. PubMed ID: 21651557
[TBL] [Abstract][Full Text] [Related]
2. The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: An in vitro study.
Bromek E; Haduch A; Daniel WA
Eur J Pharmacol; 2010 Jan; 626(2-3):171-8. PubMed ID: 19818757
[TBL] [Abstract][Full Text] [Related]
3. The cytochrome P450 2D-mediated formation of serotonin from 5-methoxytryptamine in the brain in vivo: a microdialysis study.
Haduch A; Bromek E; Kot M; Kamińska K; Gołembiowska K; Daniel WA
J Neurochem; 2015 Apr; 133(1):83-92. PubMed ID: 25581337
[TBL] [Abstract][Full Text] [Related]
4. The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals.
Fusa K; Takahashi I; Watanabe S; Aono Y; Ikeda H; Saigusa T; Nagase H; Suzuki T; Koshikawa N; Cools AR
Neuroscience; 2005; 130(3):745-55. PubMed ID: 15590157
[TBL] [Abstract][Full Text] [Related]
5. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
Biggs CS; Starr MS
Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine and tyramine increase endogenous ganglionic morphine and dopamine levels in vitro and in vivo: cyp2d6 and tyrosine hydroxylase modulation demonstrates a dopamine coupling.
Zhu W; Mantione KJ; Shen L; Cadet P; Esch T; Goumon Y; Bianchi E; Sonetti D; Stefano GB
Med Sci Monit; 2005 Nov; 11(11):BR397-404. PubMed ID: 16258388
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 2E1 in the substantia nigra: relevance for dopaminergic neurotransmission and free radical production.
Shahabi HN; Andersson DR; Nissbrandt H
Synapse; 2008 May; 62(5):379-88. PubMed ID: 18288650
[TBL] [Abstract][Full Text] [Related]
8. Dopamine formation from tyramine by CYP2D6.
Hiroi T; Imaoka S; Funae Y
Biochem Biophys Res Commun; 1998 Aug; 249(3):838-43. PubMed ID: 9731223
[TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with asenapine affects cytochrome P450 2D (CYP2D) in rat brain and liver. Pharmacological aspects.
Danek PJ; Bromek E; Haduch A; Daniel WA
Neurochem Int; 2021 Dec; 151():105209. PubMed ID: 34666077
[TBL] [Abstract][Full Text] [Related]
10. Disulfiram and diethyldithiocarbamate intoxication affects the storage and release of striatal dopamine.
Vaccari A; Saba PL; Ruiu S; Collu M; Devoto P
Toxicol Appl Pharmacol; 1996 Jul; 139(1):102-8. PubMed ID: 8685891
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cytochrome P450 2E1 induces an increase in extracellular dopamine in rat substantia nigra: a new metabolic pathway?
Nissbrandt H; Bergquist F; Jonason J; Engberg G
Synapse; 2001 Jun; 40(4):294-301. PubMed ID: 11309845
[TBL] [Abstract][Full Text] [Related]
12. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
[TBL] [Abstract][Full Text] [Related]
13. Early changes in neuropeptide mRNA expression in the striatum following reserpine treatment.
Harrison MB; Kumar S; Hubbard CA; Trugman JM
Exp Neurol; 2001 Feb; 167(2):321-8. PubMed ID: 11161620
[TBL] [Abstract][Full Text] [Related]
14. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.
Biggs CS; Fisher A; Starr MS
Synapse; 1998 Nov; 30(3):309-17. PubMed ID: 9776134
[TBL] [Abstract][Full Text] [Related]
15. Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat.
Swanson CJ; Perry KW; Koch-Krueger S; Katner J; Svensson KA; Bymaster FP
Neuropharmacology; 2006 May; 50(6):755-60. PubMed ID: 16427661
[TBL] [Abstract][Full Text] [Related]
16. Determination of reactive oxygen species associated with the degeneration of dopaminergic neurons during dopamine metabolism.
Yamato M; Kudo W; Shiba T; Yamada KI; Watanabe T; Utsumi H
Free Radic Res; 2010 Mar; 44(3):249-57. PubMed ID: 20014978
[TBL] [Abstract][Full Text] [Related]
17. Contribution of vesicular and cytosolic dopamine to the increased striatal dopamine efflux elicited by intrastriatal injection of dexamphetamine.
Watanabe S; Aono Y; Fusa K; Takada K; Saigusa T; Koshikawa N; Cools AR
Neuroscience; 2005; 136(1):251-7. PubMed ID: 16181742
[TBL] [Abstract][Full Text] [Related]
18. HIF prolyl hydroxylase inhibition augments dopamine release in the rat brain in vivo.
Witten L; Sager T; Thirstrup K; Johansen JL; Larsen DB; Montezinho LP; Mørk A
J Neurosci Res; 2009 May; 87(7):1686-94. PubMed ID: 19156859
[TBL] [Abstract][Full Text] [Related]
19. Melatonin Supports CYP2D-Mediated Serotonin Synthesis in the Brain.
Haduch A; Bromek E; Wójcikowski J; Gołembiowska K; Daniel WA
Drug Metab Dispos; 2016 Mar; 44(3):445-52. PubMed ID: 26884482
[TBL] [Abstract][Full Text] [Related]
20. Effects of aging on the interaction between glutamate, dopamine, and GABA in striatum and nucleus accumbens of the awake rat.
Segovia G; Del Arco A; Mora F
J Neurochem; 1999 Nov; 73(5):2063-72. PubMed ID: 10537066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
